{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:43:45Z","timestamp":1790664225098,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41391-018-0032-2","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T20:13:36Z","timestamp":1519762416000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"21","author":[{"given":"Jurate","family":"Noreikaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Amitharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar K.","family":"Somani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavan Prasad","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"32_CR1","unstructured":"Available at: \n                    http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer#heading-Zero\n                    \n                  ."},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","volume":"62","author":"A Carignan","year":"2012","unstructured":"Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62:453\u20139.","journal-title":"Eur Urol"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.eururo.2008.03.033","volume":"54","author":"AM Bootsma","year":"2008","unstructured":"Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008;54:1270\u201386.","journal-title":"Eur Urol"},{"key":"32_CR4","first-page":"115","volume":"34","author":"M Yang","year":"2009","unstructured":"Yang M, Zhao X, Wu Z, Xiao N, Lu C. Meta-analysis of antibiotic prophylaxis use in transrectal prostatic biopsy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009;34:115\u201323.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0090-4295(98)00296-9","volume":"52","author":"DA Kapoor","year":"1998","unstructured":"Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998;52:552\u20138.","journal-title":"Urology"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353\u201365.","journal-title":"Eur Urol"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FME Wagenlehner","year":"2013","unstructured":"Wagenlehner FME, van Oostrum E, Tenke P, Tandogdu Z, \u00c7ek M, Grabe M, et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a Prospective Multinational Multicentre Prostate Biopsy Study. Eur Urol. 2013;63:521\u20137.","journal-title":"Eur Urol"},{"issue":"1 Suppl","key":"32_CR8","first-page":"S12","volume":"189","author":"RK Nam","year":"2013","unstructured":"Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2013;189(1 Suppl):S12\u20137.","journal-title":"J Urol"},{"key":"32_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.juro.2012.10.005","volume":"189","author":"S Loeb","year":"2013","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol. 2013;189:867\u201370.","journal-title":"J Urol"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","volume":"186","author":"S Loeb","year":"2011","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011;186:1830\u20134.","journal-title":"J Urol"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/iju.12634","volume":"22","author":"E Anastasiadis","year":"2015","unstructured":"Anastasiadis E, van der Meulen J, Emberton M. Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. 2015;22:181\u20136.","journal-title":"Int J Urol"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00345-016-1867-6","volume":"35","author":"T Cai","year":"2017","unstructured":"Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, et al. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. 2017;35:221\u20138.","journal-title":"World J Urol"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.aju.2016.05.003","volume":"14","author":"AM Fahmy","year":"2016","unstructured":"Fahmy AM, Kotb A, Youssif TA, Abdeldiam H, Algebaly O, Elabbady A. Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a prospective randomised study. Arab J Urol. 2016;14:228\u201333.","journal-title":"Arab J Urol"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.acuro.2014.01.002","volume":"38","author":"F Lista","year":"2014","unstructured":"Lista F, Redondo C, Meilan E, Garcia-Tello A, Ramon de Fata F, Angulo JC. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin. Actas Urol Esp. 2014;38:391\u20136.","journal-title":"Actas Urol Esp"},{"key":"32_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000342370","volume":"89","author":"S Ongun","year":"2012","unstructured":"Ongun S, Aslan G, Avkan-Oguz V. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate. Urol Int. 2012;89:439\u201344.","journal-title":"Urol Int"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.5489\/cuaj.3068","volume":"9","author":"V Sen","year":"2015","unstructured":"Sen V, Aydogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, et al. The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: a prospective, randomized, and controlled clinical study. Can Urol Assoc J. 2015;9:E863\u20137.","journal-title":"Can Urol Assoc J"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","volume":"34","author":"GC Schito","year":"2009","unstructured":"Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407\u201313.","journal-title":"Int J Antimicrob Agents"},{"key":"32_CR18","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: \n                    http:\/\/handbook.cochrane.org\n                    \n                  . Accessed March 2017."},{"key":"32_CR19","unstructured":"Reeves, B, Shea, B, Wells, G. Classifying non-randomised studies (NRS) and the assessing the risk of bias for a systematic review. Paper presented at: Workshop at 18th Cochrane Colloquium; 2010; Keystone, CO, USA.: Cochrane Colloquium; 2010."},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"32_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1592\/phco.28.2.235","volume":"28","author":"AM Nicasio","year":"2008","unstructured":"Nicasio AM, Kuti JL, Nicolau DP. The current state of multidrug-resistant Gram-negative bacilli in North America. Pharmacother J Human Pharmacol Drug Ther. 2008;28:235\u201349.","journal-title":"Pharmacother J Human Pharmacol Drug Ther"},{"key":"32_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","volume":"45","author":"H Yigit","year":"2001","unstructured":"Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1093\/cid\/cit704","volume":"58","author":"BJ Gardiner","year":"2014","unstructured":"Gardiner BJ, Mahony AA, Ellis AG, Lawrentschuk N, Bolton DM, Zeglinski PT, et al. Is fosfomycin a potential treatment alternative for multidrug-resistant Gram-negative prostatitis? Clin Infect Dis. 2014;58:e101\u20135.","journal-title":"Clin Infect Dis"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","volume":"47","author":"AI Nilsson","year":"2003","unstructured":"Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother. 2003;47:2850\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"32_CR25","unstructured":"NICE Guidelines. Multidrug resistant urinary tract infections: fosfomycin trometamol. 2013. Available at: \n                    https:\/\/www.nice.org.uk\/advice\/esuom17\/chapter\/key-points-from-the-evidence\n                    \n                  . Accessed 27 August 2017"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jac\/dks401","volume":"68","author":"D Batura","year":"2013","unstructured":"Batura D, Gopal Rao G. The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother. 2013;68:247\u20139.","journal-title":"J Antimicrob Chemother"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0032-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0032-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:03Z","timestamp":1684618383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-018-0032-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1038\/s41391-018-0032-2","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"16 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}